Ilana Schlam
- Oncology top 10%
- HER2/EGFR in Cancer Research 19
- Cancer Immunotherapy and Biomarkers 6
- Cancer Treatment and Pharmacology 5
-
- Breast Cancer Treatment Studies 8
-
- Multiple Myeloma Research and Treatments 4
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Chronic Lymphocytic Leukemia Research 7
-
- Advanced Breast Cancer Therapies 12
- Co-authors
- Sandra M. SwainSara M. TolaneyPaolo TarantinoRafaël FonsecaSinto SebastianJill AdamskiFilipa LynceMargaret E. Gatti‐Mays
- Cited by
- OncologyCancer ResearchHematology
- Journals
- Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Ilana Schlam
38 papers receiving 527 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 324
- Cancer Research 93
- Hematology 67
- Radiology, Nuclear Medicine and Imaging 116
- Genetics 53
Countries citing papers authored by Ilana Schlam
This map shows the geographic impact of Ilana Schlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilana Schlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilana Schlam more than expected).
Fields of papers citing papers by Ilana Schlam
This network shows the impact of papers produced by Ilana Schlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilana Schlam. The network helps show where Ilana Schlam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ilana Schlam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 6 | |
| 10 | 2023 | 21 | |
| 11 | 2023 | 16 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 12 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2022 | 10 | |
| 17 | 2022 | 8 | |
| 18 | 2021 | 24 | |
| 19 | 2017 | 1 | |
| 20 | 2016 | 31 |
About Ilana Schlam
Ilana Schlam is a scholar working on Oncology, Cancer Research and Genetics, having authored 41 papers that have together received 535 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (12 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Breast Cancer Treatment Studies (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Treatment and Pharmacology (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Oncology (324 citations), Cancer Research (93 citations) and Hematology (67 citations). Ilana Schlam has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Sandra M. Swain, Sara M. Tolaney, Paolo Tarantino, Rafaël Fonseca, Sinto Sebastian, Jill Adamski, Filipa Lynce, Margaret E. Gatti‐Mays, Harini A. Chakkera and Stefania Morganti. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.